Literature DB >> 33166649

The potential of mitochondrial modulation by neuroglobin in treatment of neurological disorders.

Armita Mahdavi Gorabi1, Saeed Aslani2, George E Barreto3, Eliana Báez-Jurado4, Nasim Kiaie1, Tannaz Jamialahmadi5, Amirhossein Sahebkar6.   

Abstract

Neuroglobin is the third member of the globin family to be identified in 2000 in neurons of both human and mouse nervous systems. Neuroglobin is an oxygen-binding globin found in neurons within the central nervous system as well as in peripheral neurons, that produces a protective effect against hypoxic/ischemic damage induced by promoting oxygen availability within the mitochondria. Numerous investigations have demonstrated that impaired neuroglobin functioning is implicated in the pathogenesis of multiple neurodegenerative disorders. Several in vitro and animal studies have reported the potential of neuroglobin upregulation in improving the neuroprotection through modulation of mitochondrial functions, such as ATP production, clearing reactive oxygen species (ROS), promoting the dynamics of mitochondria, and controlling apoptosis. Neuroglobin acts as a stress-inducible globin, which has been associated hypoxic/ischemic insults where it acts to protect the heart and brain, providing a wide range of applicability in the treatment of human disorders. This review article discusses normal physiological functions of neuroglobin in mitochondria-associated pathways, as well as outlining how dysregulation of neuroglobin is associated with the pathogenesis of neurodegenerative disorders.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; Apoptosis; Mitochondria; Neurodegenerative diseases; Neuroglobin; Oxidative stress

Mesh:

Substances:

Year:  2020        PMID: 33166649     DOI: 10.1016/j.freeradbiomed.2020.11.002

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  4 in total

1.  Proteomic and Bioinformatic Investigation of Altered Pathways in Neuroglobin-Deficient Breast Cancer Cells.

Authors:  Michele Costanzo; Marco Fiocchetti; Paolo Ascenzi; Maria Marino; Marianna Caterino; Margherita Ruoppolo
Journal:  Molecules       Date:  2021-04-20       Impact factor: 4.411

2.  Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases.

Authors:  María Ángeles Peinado; David Ovelleiro; María Luisa Del Moral; Raquel Hernández; Esther Martínez-Lara; Eva Siles; José Rafael Pedrajas; María Luisa García-Martín; Carlos Caro; Sebastián Peralta; María Encarnación Morales; María Adolfina Ruiz; Santos Blanco
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

Review 3.  New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin.

Authors:  Santos Blanco; Esther Martínez-Lara; Eva Siles; María Ángeles Peinado
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

Review 4.  Structural and (Pseudo-)Enzymatic Properties of Neuroglobin: Its Possible Role in Neuroprotection.

Authors:  Giovanna De Simone; Diego Sbardella; Francesco Oddone; Alessandra Pesce; Massimo Coletta; Paolo Ascenzi
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.